These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22739230)

  • 1. Subclinical celiac disease and crystal-induced kidney disease following kidney transplant.
    Capolongo G; Abul-Ezz S; Moe OW; Sakhaee K
    Am J Kidney Dis; 2012 Oct; 60(4):662-7. PubMed ID: 22739230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
    Moreland AM; Santa Ana CA; Asplin JR; Kuhn JA; Holmes RP; Cole JA; Odstrcil EA; Van Dinter TG; Martinez JG; Fordtran JS
    Gastroenterology; 2017 Apr; 152(5):1055-1067.e3. PubMed ID: 28089681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
    Maalouf NM; Tondapu P; Guth ES; Livingston EH; Sakhaee K
    J Urol; 2010 Mar; 183(3):1026-30. PubMed ID: 20096421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of Hyperoxaluria and Kidney Disease after Combined Intestine-Kidney Transplantation for Enteric Hyperoxaluria.
    Ekser B; Mangus RS; Kubal CA; Fridell JA; Powelson JA; Nagaraju S; Mihaylov P; Phillips CL; Saxena R; Goggins WC
    Am J Nephrol; 2016; 44(2):85-91. PubMed ID: 27410399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption.
    Stauffer JQ
    Am J Dig Dis; 1977 Oct; 22(10):921-8. PubMed ID: 920694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
    Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalate nephropathy in an elderly patient with newly diagnosed celiac disease - a case report.
    Zijlstra HW; Stegeman CA
    BMC Nephrol; 2023 Jun; 24(1):189. PubMed ID: 37370009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of Roux-en-Y Gastric Bypass for Successful Salvage of Renal Allograft.
    Hrebinko K; Moroni E; Ganoza A; Puttarajappa CM; Molinari M; Sood P; El Hag M; Wijkstrom M; Tevar AD
    Am Surg; 2023 Apr; 89(4):1286-1289. PubMed ID: 33631945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate nephropathy due to gastrointestinal disorders.
    Canos HJ; Hogg GA; Jeffery JR
    Can Med Assoc J; 1981 Mar; 124(6):729-33. PubMed ID: 7471017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute deterioration of renal function associated with enteric hyperoxaluria.
    Wharton R; D'Agati V; Magun AM; Whitlock R; Kunis CL; Appel GB
    Clin Nephrol; 1990 Sep; 34(3):116-21. PubMed ID: 2225562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary oxalate on a high-oxalate diet as a clinical test of malabsorption.
    Andersson H; Gillberg R
    Lancet; 1977 Oct; 2(8040):677-9. PubMed ID: 71494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
    Whittamore JM; Stephens CE; Hatch M
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria.
    Modigliani R; Labayle D; Aymes C; Denvil R
    Scand J Gastroenterol; 1978; 13(2):187-92. PubMed ID: 635458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy.
    Nasr SH; Valeri AM; Said SM; Sethi S; Nath KA; Lieske JC; Bu L
    Mayo Clin Proc; 2024 Apr; 99(4):593-606. PubMed ID: 38310502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
    Nasr SH; D'Agati VD; Said SM; Stokes MB; Largoza MV; Radhakrishnan J; Markowitz GS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1676-83. PubMed ID: 18701613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of patients with enteric hyperoxaluria.
    Asplin JR
    Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxaluria in malabsorptive states.
    Andersson H; Bosaeus I
    Urol Int; 1981; 36(1):1-9. PubMed ID: 7020204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.
    Saccomani MD; Pizzini C; Piacentini GL; Boner AL; Peroni DG
    J Urol; 2012 Aug; 188(2):566-70. PubMed ID: 22704115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.